Solid Team:Management
Our management team has the breadth of experience and passion to bring meaningful therapies to patients with Duchenne muscular dystrophy (DMD).
Ilan Ganot
Co-Founder, President and CEO
Joel Schneider, Ph.D.
Chief Operating Officer
Carl Morris, Ph.D.
Chief Scientific Officer
Erin Powers Brennan
Chief Legal Officer & Secretary
Stephen DiPalma
Interim Chief Financial Officer
Roxana Donisa Dreghici, M.D.
Senior Vice President, Head of Clinical Development